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Borderline personality disorder (BPD) and mood disorders are highly comorbid, and both 
disorders share important developmental pathways and underlying neurobiological features. 
This chapter reviews evidence for the overlap between BPD and mood disorders and presents 
an attachment and mentalizing approach to the conceptualization and treatment of patients 
with depression with and without marked BPD features. We propose that patients with BPD 
and mood disorders can be situated on a continuum, with four related features distinguishing 
individuals with depression with versus without marked BPD features: (a) the nature of their 
depressive experiences, (b) the nature of their mentalizing impairments, (c) the presence of 
insecure, but organized, attachment in response to stress and arousal versus disorganized 
attachment and (c) problems with epistemic trust versus epistemic hypervigilance. We outline 
the therapeutic implications of these views, arguing that treatments that combine a mental 
representation and mental process (i.e., mentalizing) focus may be most appropriate for 
patients with mood problems without marked BPD features. Yet, for patients with more 
marked BPD features these treatments may be iatrogenic, as these patients may have serious 
problems in establishing a therapeutic alliance and lack the reflective capacities needed for 
such treatments. For these patients, a mental process approach that focuses on restoring the 
capacity for mentalizing might be more appropriate. Preliminary empirical evidence 
supporting these assumptions is presented. 
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Considering comorbidity between depression and BPD (BPD) is important both from 
a research and a clinical perspective. Studies not only suggest that depression and BPD are 
highly comorbid, but also that comorbidity with BPD features may influence the clinical 
course as well as treatment response in depression in negative ways [1, 2]. Similarly, 
depression or dysphoria is a core feature of BPD, although studies suggest that depression in 
BPD has a different character than in MDD [3, 4]. As we will argue in this chapter, 
differences in the phenomenology of depression in BPD have often been neglected, despite 
the fact that they have very important implications for treatment and point to substantial 
differences in the development and course of these disorders.  
From a mentalizing perspective, we believe that (brief) focused treatments that are 
effective in more high-functioning patients suffering from depression are likely to be less 
effective with depressed patients with (marked) BPD features if the treatment model is not 
adapted to the specific characteristics of these patients. Patients with BPD suffer from marked 
impairments in their mentalizing capacities – that is, in their capacity to understand the self 
and others in terms of intentional mental states, such as feelings, desires, wishes, values and 
goals. Particularly in severely disturbed BPD patients, treatments that strongly rely on 
reflective capacities might actually become iatrogenic [5, 6]. We argue that the reasons for 
this lie in differences in the attachment history and impairments in mentalizing, and related 
epistemic hypervigilance [7], in patients with (severe) BPD features versus those without. 
These differences are presumed to have a negative impact on the treatment of these patients, 
as they (a) impede the development of a therapeutic alliance, a key predictor of therapeutic 
outcome in evidence-based treatments for depression, regardless of the type of treatment [8], 
and (b) are negatively related to the patient’s ability to benefit from both brief and longer-
term supportive and particularly expressive (i.e., insight-oriented) treatments [9]. As we will 
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see, although it is not yet clear whether depression and BPD are part of a spectrum of 
affective disorders, we consider it helpful from a treatment perspective to think of depressed 
patients as situated on a continuum ranging from depressed patients without BPD features to 
depressed patients with marked BPD features, necessitating a different treatment approach 
depending on their position on this continuum. Briefly, depressed patients without marked 
BPD features may benefit from a mental representations approach [10], i.e., an approach that 
focuses on distortions in the content and/or developmental level of mental representations 
(cognitive affective schemas or internal working models of self and others). Yet, the more 
patients move to the borderline spectrum, the less likely they become to benefit from this 
approach, to the point that such an approach may become iatrogenic. Such patients may 
benefit more from a mental process or mentalizing approach, where the focus is on 
distortions in processes related to the meta-cognitive ability to reflect on the self and others 
[11, 10].  
In this chapter, we first review, with an attachment/mentalizing focus in mind, 
relevant empirical research concerning comorbidity between BPD and depression, and 
similarities and differences in the etiology of these disorders. Next, we describe a 
mentalization-based spectrum of interventions for depressed patients with varying levels of 
BPD comorbidity, with different weight given to mental representation and mental process 
models depending on the severity of BPD comorbidity. We also provide preliminary 
evidence supporting the effectiveness of mentalization-based treatments in depression.  
 
Comorbidity between BPD and mood disorders 
Depression is a highly prevalent disorder, with population-based studies suggesting a 
lifetime prevalence for unipolar depression of 15%, and up to 25% in women [12-14]. 
Depression is expected to be the second most serious disorder with respect to the global 
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disease burden by the year 2020 [15]. Studies suggest that unipolar depression has a relapse 
rate of 20–30% within 3 years following a first episode, and 70-80% within 3 years in 
subjects who have had three or more depressive episodes [16]. The probability of at least one 
further episode of depression after a first episode is estimated to be almost 90% [17] and the 
average depressed patient will experience four episodes during their lifetime, each 
approximately 20 weeks in duration [18]. A notable illustration of the long-term negative 
impact of mood disorders is given by the finding that children of parents with mood disorders 
are themselves at higher risk of developing psychopathology in later life [19]; both 
internalizing and externalizing disorders are more common in the children of parents with 
mood disorders [20].  
Studies have shown that currently used pharmaceutical and psychotherapeutic 
treatments have limited efficacy for a considerable proportion of depressed individuals, with 
only around 50% of depressed patients responding to these treatments [21-23]. As a 
consequence, treatment guidelines have emphasized the need for a long-term approach in 
depression management, stressing continuation and treatment maintenance, and with a focus 
on relapse prevention [21].  
One reason for the relatively limited response of many depressed patients in current 
evidence-based treatments [e.g. 24] may lie in the high comorbidity between MDD and BPD 
[25-27, 22]. Lower response rates in depressed patients with BPD have often been reported 
[28, 29]. For instance, in a large study of 276 patients with MDD, randomized to 
interpersonal psychotherapy or pharmacotherapy, higher levels of personality pathology and 
the presence of borderline personality disorder in particular were associated with a longer 
time to remission [2]. However, some higher quality studies tend not to show an influence of 
BPD comorbidity [30]. This may be the case for at least two reasons. First, patients with 
marked BPD features (e.g., high levels of parasuicidal behavior and impulsivity) might 
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simply be excluded, particularly in high quality studies. Westen and colleagues, for instance, 
found a high correlation between the number of exclusion criteria (as an indicator of the 
quality of the study) and treatment outcome in studies of depression and anxiety [31]. 
Second, therapists who are closely supervised and monitored, as is typically the case in high-
quality studies, might be more likely to tailor their treatment and interventions. Hilsenroth 
and colleagues, for instance, showed that short-term psychodynamic psychotherapy was 
equally effective for depressed patients with and without comorbid borderline pathology. Yet 
in patients with comorbid BPD features, therapists used more structuring techniques than in 
patients without comorbid borderline pathology. These included providing structure at the 
start of therapy, suggesting specific activities between sessions, maintaining an active focus 
on treatment topics, more supportive interventions and more interventions aimed at 
examining relational patterns [29]. These adaptations in techniques are, in our opinion, not 
coincidental, as there is emerging consensus that a more active, structured and coherent 
treatment approach may be a common factor explaining the effectiveness of evidence-based 
treatments of BPD [32]. As outlined in detail in this chapter, a more active interpersonal, 
supportive and structured approach is central to MBT.  
 
The relationship between BPD and depression 
The precise nature of the relationship between depression and BPD is elusive. This 
should come as no surprise, as depression refers to (a) a psychobiological response to loss 
and defeat, (b) a symptom, and (c) a disorder [23]. BPD, in turn, has not quite shed its 
historic definitional challenge of being an “adjective in search of a noun” [33]. As is well 
known, BPD has been conceptualized as (a) a level of functioning [34, 35] encompassing a 
wide variety of personality disorders, (b) a disorder with substantial overlap/comorbidity with 
other disorders such as substance abuse disorder, posttraumatic stress disorder (PTSD) and 
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mood disorders [36, 37], (c) part of a spectrum of affective disorders (including bipolar 
disorder) – given its high comorbidity with mood disorders [38] – congruent with models of 
BPD that emphasize affect dysregulation, and depression in particular, as a key feature of 
BPD [39], yet, BPD has also been hypothesized to be part of (d) a spectrum of psychotic 
disorders [40] and (e) PTSD [41].  
A focus on descriptive diagnostic criteria and features alone may not shed further 
light on these issues [42], as disturbed mood is essential to BPD and, conversely, disturbed 
interpersonal relationships have been implicated as a cause, concomitant and consequence of 
depression [22]. This is also shown by rather unproductive attempts to decrease the 
comorbidity between BPD and mood disorders by replacing the word “depression” in the 
DSM-III-R criteria with the word “dysphoria”. While these efforts to distinguish 
phenomenologically between feelings of depression in MDD and BPD are, as we explain in 
more detail below, legitimate, they are unlikely to resolve matters, as studies suggest that 
BPD is most distinctly characterized by affective dysregulation or affective instability rather 
than dysphoria [36]. If the core problem of BPD includes instability of affect states, then 
studies investigating longitudinal relationships between MDD and BPD, although 
informative, will similarly be limited in their ability to shed light on the relationship between 
mood problems and BPD. 
From our attachment theory and mentalizing perspective, the possibility of untangling 
the Gordian knot of the relationship between depression and BPD lies in analyzing the 
differences in the developmental pathways involved in patients with depression with and 
without BPD features. Developmental factors moderate differences in symptomatology, 
phenomenology, prognosis, and treatment response. Also congruent with this emphasis on 
developmental continuities is a dimensional approach to pathology intrinsic to the NIMH’s 
Research Domain Criteria (RDoC) initiative [43]. Our focus is on the role of the behavioral 
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and neurobiological aspects of attachment and mentalizing (social cognition) in generating 
the developmental pathways that are implicated in mood disorders and BPD. Given this 
focus, differences between mood disorders and BPD are unlikely to be categorical, but the 
differences in developmental behavioral paths and underlying neurobiology are sufficient to 
warrant separate consideration, particularly as they have important but specific treatment 
implications.  
 
The mentalizing approach to BPD and mood disorders 
Similarities between BPD and mood disorders 
BPD and depression are not only highly comorbid at the symptomatic and syndrome 
levels; there is also increasing evidence for shared underlying psychosocial and 
neurobiological mechanisms. From the mentalizing perspective, findings concerning the 
powerful ties between disruptions in (a) mentalizing and attachment experiences, and (b) 
stress/affect regulation in mood disorders and BPD [44, 41] are crucial here. We discuss these 
findings and highlight commonalities between mood disorders and BPD. 
 
(a) Disruptions in mentalizing and attachment 
The mentalizing approach originally developed in an attempt to understand patients 
with marked borderline pathology, and their difficulties in reflecting on the self and others, 
specifically in attachment contexts [45, 46]. In these circumstances, these patients tend to lose 
the capacity for more controlled, reflective functioning concerning the self, others, and the 
relationship between the self and others, and to switch increasingly to so-called 
nonmentalizing modes of experiencing subjectivity. These primitive, pre-mentalizing modes 
of function include psychic equivalence (in which mental events are considered to have the 
same status as physical reality), teleological thinking (the assumption that emotional 
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difficulties can be solved by doing, for instance, anger can be resolved by destruction of 
property or violence) and pretend mode (when subjectivity becomes completely separated 
from reality and mentalizing becomes excessive but lacking in depth and genuine meaning).  
Mentalizing has the function of maintaining an illusion of self-integration or self-
coherence by linking observed acts and experiences to plausible intentional states [47]. 
Because of the fragmentation of the self that results from the use of nonmentalizing modes, 
BPD patients are often characterized by a tendency to externalize “alien-self” parts, which are 
felt to threaten the self from within, in an attempt to restore coherence in the self-experience 
[48]. This need to externalize may be expressed in acting-out behavior, self-harm, and/or a 
tendency to coerce others into specific roles (i.e., that of the one who neglects, abandons, or 
criticizes the patient). Studies increasingly suggest [49] that this tendency might be rooted in 
disturbed attachment relationships and attachment trauma in particular in interaction with 
biological predisposition [50, 51]. 
There is good evidence to suggest that both depression and BPD are associated with 
impairments in mentalizing and in the neural circuits that are implicated in mentalizing [49, 
52], including the medial prefrontal cortex, amygdala, hippocampus, and ventromedial parts 
of the basal ganglia [53-55]. Moreover, these dysfunctions have been linked to failure of top-
down regulation and/or impairments in bottom-up input, reflecting hypersensitivity of limbic 
structures that in concert may be responsible for the impairments in autonomic regulation, 
emotion regulation, and neuroendocrine stress responses typically observed in mood disorder 
[53-55] and, in more extreme forms, in BPD [49].  
The link between these formulations of the features typical of patients with BPD and 
patients with mood disturbances is obvious: many BPD patients suffer from mood problems 
because of attachment disruptions and resulting problems in self-esteem; and these issues 
are easily reactivated by current stress and arousal, particularly in interpersonal relationships. 
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Mood problems further impair mentalizing, leading to a vicious cycle characterized by 
hypervigilance to rejection/abandonment and increasing depression. Similarly, 
hypersensitivity to experiences of failure (either real or imagined), which have also been 
implicated in vulnerability to depression [56], trigger feelings of being unloved and unwanted 
[6], a feature typical of BPD patients. 
Depression can thus be seen as a basic psychobiological reaction to experiences of 
(anticipated) loss and separation [57], either directly through the threat of loss and 
abandonment or indirectly through experiences of failure [58]. As such, depression can be 
expected to be central in BPD. Strong rejection sensitivity is indeed typical of BPD patients 
and has even been conceptualized as the interpersonal phenotype of BPD [59, 44]. Similarly, 
self-criticism (e.g., evaluation of the emotional self as characterized by unworthiness, 
inferiority, failure, guilt, and chronic fear of disapproval and rejection) is a key part of BPD 
[56]. Blatt and colleagues have argued in this context that problems concerning rejection 
sensitivity and dependency can be situated on a continuum ranging from more psychotic to 
more high-functioning histrionic levels of functioning [60]. The importance of mood 
problems in BPD, and thus comorbidity between mood disorders and BPD, should thus not 
surprise us. Recently, negative self-referential processing in combination with emotionality 
has been suggested to be an endophenotype of treatment-refractory patients who fail to 
achieve a satisfactory treatment response [61, 62]. 
In an attempt to regulate increasing levels of arousal (including depressed mood), 
individuals may begin to rely on secondary attachment strategies (i.e., attachment 
hyperactivating and deactivating strategies). This will likely bring about further limitations in 
mentalizing with regard to both one’s own and other people’s motivations and desires [63]. 
Increasing levels of depressed mood lead to further increases in arousal and stress levels, 
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resulting in impairments and distortions in mentalization, which in turn lead to a loss of 
resilience in the face of stress, and to a vicious cycle of increasingly depressed mood.  
Congruent with these assumptions, insecure attachment has been related to 
vulnerability to both depression and BPD in children, adolescents, and adults [64, 65, 49]. 
Thus, both disorders share important developmental features. Likewise, research indicates 
that vulnerability to both depression and BPD is associated with personality traits or 
cognitive-affective schemas that are rooted in disruptive attachment experiences, notably 
interpersonal dependency and self-critical perfectionism [66-69]. Insecure attachment also 
prospectively predicts recurrent depression, more depressive episodes and residual 
symptoms, longer use of antidepressants, impairments in social functioning [70], and suicide 
[65]. 
The central role of attachment experiences in the causation of depression and BPD is 
further emphasized by findings concerning the central importance of developmental 
adversity and disruptive attachment experiences (in particular abuse and neglect) in the 
etiology of both disorders[41, 71], leading to a dysregulation of stress and affect regulation 
systems.  
 
(b) Disruptions in stress and affect regulation 
Early adversity has profound effects on the developing stress system: indeed, studies 
suggest that attachment experiences play a key role in the developing stress system [72, 73 , 
6]. Secure attachment experiences seem to buffer the effects of stress in early development, 
leading to a so-called “adaptive hypoactivity” of the hypothalamic–pituitary–adrenal (HPA) 
axis in early development, and to resilience in the face of adversity in later life [74]. By 
contrast, research [73, 75-77, 74] shows that insecure attachment experiences are associated 
with increased vulnerability to stress, as expressed, for instance, in HPA axis dysfunctions.  
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Together, these findings may at least partially explain the mounting evidence that 
vulnerability to depression is associated with an increased stress response to both daily and 
major life stressors [78, 41], explaining, at least in part, high comorbidity and overlap with 
BPD. Several studies do indeed suggest that insecure attachment experiences mediate the 
relationship between early adversity and vulnerability to depression through impaired affect 
regulation, stress responsivity, and social problem-solving skills [79, 80] – features that 
are also typical of BPD patients [81]. 
 Moreover, although the evidence is still somewhat equivocal [82], there is some 
evidence that increased stress responsivity as a result of early or later adversity is particularly 
pronounced in individuals with genetic liability, which might also be the case in BPD [50]. 
For instance, studies suggest that a polymorphism of the 5HTT gene may be associated with 
increased stress sensitivity, resulting in increased vulnerability to depression [82] as well as 
BPD, although recent meta-analyses have called these findings into question [83, 82]. 
 There is now also evidence [76, 84, 75, 85, 86] that the neuropeptides oxytocin and 
vasopressin, which are involved in neural systems underlying attachment [87, 76], play a key 
role in disrupted stress regulation in mood disorders and BPD. Oxytocin plays a role in 
affiliative behavior (including pair bonding, maternal care, and sexual behavior) as well as in 
social cognition [88, 89], and in reducing behavioral and neuroendocrinological responses to 
stress [76].  
Early adverse attachment experiences are associated with decreased oxytocin levels 
and increased cortisol response [90, 91, 41]. High levels of attachment anxiety and avoidance 
have been associated with polymorphisms in the oxytocin receptor gene in patients with 
unipolar depression [92], and studies have also found dysregulated peripheral oxytocin 
release in depressed women [93]. Gotlib and colleagues reported that adolescent girls who 
were at risk for depression showed decreased activation in the reward processing system (and 
Psychodynamic Treatment for BPD and Mood Disorders 
 
13 
particularly striatal areas), suggesting a marked reduced sensitivity to reward [94]. Similarly, 
low endogenous levels of oxytocin, polymorphisms in oxytocin-related genes, and negative 
(instead of positive) effects of oxytocin administration have also been documented in BPD 
[95-97, 93]. These findings suggest at least some overlap between depression and BPD in 
terms of a dysfunction of the oxytocinergic system (underlying attachment behavior and 
stress regulation), which may also explain the inverse effects of oxytocin administration in 
these patients [98]. 
What then is the difference? 
Although patients with depression with and without BPD features probably need to be 
situated on a continuum with regard to underlying psychosocial and neurobiological 
mechanisms, at least four related differences seem to distinguish these groups of patients: (a) 
the nature of depressive experiences, (b) the nature of mentalizing deficits, which are more 
extreme in BPD patients in terms of both intensity and content, (c) the nature of attachment 
experiences, with BPD patients showing more disorganized attachment features as a result of 
more severe disruptions of the attachment system (which may be in part related to genetic as 
well as environmental factors), and (d) the profound loss of mentalizing in BPD patients, 
which, coupled with disorganized attachment features, typically leads, in the psychic 
equivalence mode, to strong and painful feelings of emptiness/lack of meaning. As a result, 
this intensifies feelings of identity diffusion and hypersensitivity to rejection, and increases 
pressure to externalize alien self-parts in a teleological attempt to get rid of these feelings. 
These tendencies, in our opinion, lead to a profound lack of epistemic trust and an epistemic 
hypervigilance, which necessitates a different treatment approach, as these features seriously 
threaten the ability to form a working alliance, and these patients typically lack the reflective 
capacities that are needed in many current evidence-based treatments for depression. We 
review each of these issues in more detail below. 
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When depression is not just depression 
More than twenty years ago, Drew Westen and colleagues noted that “depression is 
not just depression” in BPD patients [3]. Indeed, studies since have amply demonstrated the 
phenomenologically very different nature of depression in BPD patients. Patients with 
marked BPD features have greater affective instability (which makes the relationship 
between stressful experiences and the onset of depression, so typical of depressed patients 
without such features, less obvious in BPD patients) [69]. Studies also suggest that patients 
with BPD features also have a greater painfulness of depressive experiences as evidenced by 
higher scores on self-report, but not observation-based, measures of depression [99, 4, 100]; 
more feelings of emptiness and diffuse negative affectivity [3]; higher levels of self-criticism 
[101, 102]; and a greater focus on fears of abandonment [103, 4] and shame [104, 105], 
which predict self-destructive behaviors, impulsivity, and interpersonal distress [4, 106]. 
Profound mentalizing impairments 
From a phenomenological perspective, depression in patients with marked BPD 
features reflects a more severely non-mentalizing way of experiencing subjectivity as 
compared to depressed patients without such features. There are differences in intensity, but 
these also reflect differences in the quality (i.e., content) of mentalizing failures, which may 
have etiological underpinnings. Because of the ready loss of mentalizing in BPD patients, 
feelings of rejection and abandonment, in a psychic equivalence mode, can feel extremely 
painful in these patients. Feelings of unattractiveness are felt as an absolute truth. Zanarini 
and colleagues [107] noted this aspect of BPD phenomenology. We have attributed this to an 
underlying disorganization of the self, rooted in disorganized attachment and leading to alien-
self experiences (e.g., “critical introjects”) and the risk that increasing incoherence of the self 
generates stronger pressure to externalize (project and attribute to others) the alien-self 
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experience [108]. Greater self-harm and destructiveness may result, and these features also 
negatively influence the therapeutic relationship as therapists are more likely to become 
entangled in difficult transference–countertransference relationships [109-111].  
The so-called “depressive realism” often reflects a more accurate and less rose-
colored view of reality in those with depression without marked BPD features [112, 113]. In 
BPD patients, depressive realism shifts into psychic equivalence and often borders on the 
complete absence of an experience of symbolic representations or hypomentalizing: there is 
really nothing that is worth living for, the self feels completely empty, unattractive and 
unworthy.  
Disturbed mood further impairs individuals’ ability to mentalize. When the individual 
is depressed, mentalizing is likely to be distorted for both MDD and BPD patient, but in the 
latter group depression can trigger the re-emergence – either temporarily or more chronically 
– of modes of thinking that antedate full mentalizing, which can lead BPD patients to devalue 
the significance of subjective experience and prioritize physically observable outcomes 
(teleology, or judging experience solely by its physical outcomes). The loss of mentalizing 
leads patients to feel unable to accept anything other than a modification in the realm of the 
physical as a true index of the intentions of the other. This may be linked to the extreme focus 
on exterior indicators of mental states (such as gestures and expressions). The weight of 
evidence suggests that mentalizing tasks that focus attention on external features cause fewer 
problems for these patients; indeed BPD patients have been found to be hypersensitive to 
facial expressions [e.g., 114, 115, 116].  
The ease with which BPD patients can lose reflective, controlled mentalizing 
probably also contributes to the ready emergence of a teleological mode of thinking. The 
failure of reflective mentalizing in BPD has been repeatedly demonstrated using attachment 
narratives [117-119] and has been shown to be reversible by psychotherapy [120]. Other 
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studies have shown BPD patients to be impaired on the Movie for the Assessment of Social 
Cognition (MASC), a video-based test of mentalizing which requires participants to 
recognize the mental state of characters as they interact in an everyday life group scenario 
involving relationships [121-123]. In patients with marked BPD features, a teleological 
stance often leads to frantic attempts to get attachment figures, including the therapist, to 
show that they care, like, and love the patient. Hence, patients may demand longer or more 
sessions, and, in more extreme cases, demand to be touched, caressed or hugged by their 
therapist, which may lead to boundary violations. While this can also occur in depressed 
patients without marked BPD features, such tendencies are mostly understood to be “not for 
real”. 
In psychic equivalence and the teleological mode of functioning, the subjective 
experience is one where the implication of failing to achieve the physical outcome is 
catastrophic and can feel like a choice between life and death. Suicidal ideation deserves 
special attention here, particularly as studies suggest highly increased rates of suicidal 
behavior in depressed patients with BPD features. A recent population-based study, for 
instance, showed that comorbid BPD features were strongly associated with suicide attempts 
in patients with major depressive disorder [124]. Similarly, Stringer and colleagues showed, 
in a study of 1838 depressed patients, that the suicide attempt rate ratio increased by a 
staggering 33% for every unit increase in BPD features [1]. Sharp and colleagues showed that 
BPD features predicted suicidal ideation (and self-harm more generally) over and above 
major depressive disorder in a sample of 156 adolescents admitted to a specialized treatment 
setting [125].  
The tendency to function in the teleological mode may explain the higher levels of 
impulsivity and aggression that make these patients more prone to suicidal behavior [1]. In 
the case of depressed patients without marked BPD features, thoughts and feelings 
Psychodynamic Treatment for BPD and Mood Disorders 
 
17 
concerning suicide are more embedded within an interpersonal context that is more readily 
available to the patients, with suicidal thoughts involving harsh self-criticism and anger 
turned toward the self, fantasies about killing hated parts of the self, and omnipotent fantasies 
about reunion with lost loved ones. In the case of depression and suicidal tendencies in BPD 
patients, these interpersonal links are less clear to the patient and it often seems to be the too-
realness of painful inner states (feelings and emotions) that primarily leads patients to ideas 
or acts of suicide in an attempt to silence inner feelings of pain.  
A feature of BPD phenomenology that distinguishes the condition from simple 
depression is hypermentalizing. Hypomentalizing, particularly in BPD patients, is often 
followed by extreme pretend mode or hypermentalizing accounts in which the relation to 
reality is severed [126, 123]. In the pretend mode, ideas form no bridge between inner and 
outer reality; the mental world is no longer fully coupled with external reality; explicit 
mentalizing has been overridden by implicit mentalizing; an excessive internal focus is 
unchecked by reference to external indicators; there is poor belief-desire reasoning, 
vulnerability to fusion with others’ identity, and a tendency to become lost in the complexity 
of the world of beliefs and desires with which physical reality is only loosely coupled. In 
hypermentalizing, groundless inferences are made about mental states, sometimes 
reminiscent of confabulation [123, 127]. Hypermentalizing accounts of interpersonal events 
often strike the clinician as overly analytical, repetitive and lengthy in nature, colored by 
depressive themes (e.g., guilt and shame). In BPD patients, hypermentalizing accounts are 
typically more self-serving (e.g., to receive attention or compassion, or to control or coerce 
others), and affectively overwhelming interpersonal accounts that often lack any coherence. 
Mentalizing impairments in depressed patients with marked BPD features manifest in 
extreme hypermentalization–hypomentalization cycles.  
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The limitations of mentalizing may account for the need for long-term interventions 
for BPD [128], in contrast to the effectiveness of a range of short-term therapies for MDD 
patients [129]. We would argue that mentalizing deficits can generate problems in the 
formation of therapeutic alliances in treatments of BPD patients [130, 131]. Brief, focused 
treatment packages assume a capacity for insight and reflectiveness that is likely to exceed 
the patients’ abilities to mentalize effectively, particularly under conditions of arousal. 
Increased arousal could further disrupt the possibility of effective higher order cognitive 
function.  
If therapy activates the attachment system, which in turn increases the risk of 
interpersonal misunderstanding, there will be a risk of getting into a vicious cycle of 
increasing self-criticism, rumination, helplessness, and suicidal thoughts. We have 
consistently argued that in order for BPD patients to benefit from psychotherapy, the initial 
focus must be on the recovery of mentalization, which provides the necessary basis for the 
patient to engage in a reflective psychological process [32, 132]. Depressed patients with 
marked BPD features (and chronic depressed patients more generally, many of whom have 
BPD features), thus seem to have lost the “self-righting tendency” that is associated with the 
capacity for controlled mentalizing.  
Attachment in BPD and mood disorders  
This brings us to attachment issues. We believe that the typical features of depression 
in those individuals with marked BPD features are related to a disorganization of the 
attachment system, rather than the organized insecure attachment strategies that are typical of 
depressed patients without marked BPD comorbidity. Whereas organized types of insecure 
attachment (i.e., anxious-ambivalent and anxious-avoidant) reflect relatively stable ways of 
dealing with stress and arousal (i.e., respectively using predominantly attachment 
hyperactivating and deactivating strategies), individuals with disorganized attachment often 
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show marked variability in the use of attachment hyperactivating and hypoactivating 
strategies, reflecting a lack of a coherent, organized attachment strategy when faced with 
increasing stress and arousal [133]. Studies suggest that for these individuals the caregiver 
has served as a source of both fear and reassurance, so that activation of the attachment 
system produces strong conflicting motivations. Research has found that histories of 
prolonged or repeated separation [134], intense marital conflict [135], and/or severe neglect 
or physical or sexual abuse are often associated with this pattern of attachment [136], 
although the evidence linking such developmental histories to BPD longitudinally is still 
quite limited. However, studies do suggest that frightened or frightening states of mind [137] 
in attachment figures prospectively predict BPD features. Lyons-Ruth and colleagues, for 
instance, found that such severely disrupted maternal communication and maltreatment were 
independent predictors of BPD symptoms at age 18 [138]. Early separation from the primary 
caregiver has been found to predict a slower decline of BPD scores through adolescence 
[139]. The role of disorganized attachment in BPD may account for (a) the often-noted fears 
of abuse that are triggered by attachment relationships in these individuals, (b) the fact that 
their attachment system is extremely readily activated, and (c) that while they seem 
constantly preoccupied with attachment relationships, they tend also to engage in 
idealization-denigration and push-pull cycles in relationships.  
Few studies have compared attachment in depressed patients with and without marked 
BPD comorbidity [6], and existing studies on attachment in depression often fail to control 
for comorbidity with BPD and trauma. In an unusual study, Choi-Kain and colleagues [140] 
showed that patients with mood disorder could be differentiated from those with BPD in 
terms of attachment style, even on self-report questionnaires, consistent with the case being 
built here. Both MDD and BPD patients showed greater preoccupation and fearfulness than 
community controls, in agreement with other studies that have found higher levels of insecure 
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attachment (and particularly organized insecure attachment styles) in patients with MDD 
[141, 142, 70, 64, 80]. However, BPD patients had higher levels of both preoccupation and 
fearfulness, and only patients with BPD simultaneously showed preoccupation and 
fearfulness. These findings suggest more profound disruptions of attachment in BDP than 
MDD patients and may be indicative of the lack of any functional regulation strategy to 
reduce attachment distress that we have hypothesized [143-145]. These assumptions are 
further supported by the findings by Shedler, Westen, and colleagues with the Shedler-
Westen Assessment Procedure (SWAP); based on clinician ratings, they found that a 
borderline-dysregulated spectrum emerged as a separate and coherent personality prototype 
characterized by strong fears of rejection, abandonment, and isolation, and by becoming 
attached quickly and intensely [146]. 
Attachment and epistemic trust/hypervigilance  
Finally, more recently, we have argued on the basis of pioneering work by Dan 
Sperber [7, 147] and Corriveau et al. [148] that secure attachment experiences not only pave 
the way for the acquisition of mentalizing, but also, more generally, for the formation of 
“epistemic trust”, defined as an individual’s willingness to consider communication 
conveying new knowledge from someone as trustworthy, generalizable, and relevant to the 
self [9]. Corriveau’s study demonstrated that attachment security increased the likelihood of 
an infant trusting the reliability of a communication source when it was reasonably credible, 
while preoccupied and anxiously attached children over-relied on the views of the attachment 
figure (mother) in an ambiguous situation [148]. The latter pattern could be considered the 
consequence of a kind of epistemic dependency, in which the child has developed a chronic 
lack of confidence in their own understanding. While secure attachment empowered a child’s 
confidence in their own experience, beliefs and judgment, an avoidant attachment history was 
associated with epistemic mistrust, leading to a tendency for the child to reject even plausible 
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information from the attachment figure and an increased likelihood of accepting the 
information coming from a stranger. Finally, disorganized attachment, rooted presumably in a 
history of misattunement, led to mistrust of information from both attachment figures and 
strangers. 
It seems to us that attachment disorganization therefore leaves the individual in a 
terrible quandary about “whom to trust?” The person whose insecure attachment history 
precludes confidence in their own experiences and beliefs is left in a permanent and 
irresolvable state of epistemic searching. They seek others to confirm or deny their own 
understanding, but they are also not able to trust the information they receive, ultimately 
generating a state of epistemic hypervigilance. While organized insecure attachment styles 
can be associated with either considerable epistemic mistrust (in the case of avoidant 
attachment) or excessive trust (in the case of preoccupied-anxious attachment), we believe 
that disorganized attachment is associated, particularly in attachment contexts, with a 
confusing combination of low epistemic trust and epistemic dependency, leading to marked 
epistemic hypervigilance. Of course, such a disorganized state would place serious limits on 
these patients’ capacity to benefit from more insight-oriented psychotherapeutic approaches.  
Within the therapeutic context, the particular and profound difficulties in 
communication that arise from epistemic hypervigilance often give the BPD patient a 
peculiarly rigid and unreachable quality, often leading to intense feelings of frustration on the 
part of the therapist. It is now to the question of how mentalization-based treatments can 
serve to reach patients with mood disorders with marked features of BPD that we will turn. 
 
Psychodynamic Treatment for BPD and Mood Disorders 
 
22 
Implications for treatment 
A spectrum of mentalization-based interventions 
Throughout this chapter we have argued that a mental representation model that relies 
heavily on reflective capacities is less appropriate in the treatment of BPD patients and mood 
problems in the context of BPD, and might even be associated with iatrogenic effects. Given 
the greater propensity to revert to nonmentalizing modes, with increasing pressures to 
externalize alien-self parts, and their often profound levels of epistemic hypervigilance, these 
patients are unable to form the kind of working alliance that is typically required in these 
treatment models. Structured interventions (and brief interventions in particular) for 
depression rely upon capacities for relating to the therapist and for insight that these patients 
simply do not possess. Indeed, many current treatment models for depression are based on the 
premise that the patient has the capacity for epistemic trust or that this capacity, at the very 
least, can be reactivated relatively easily. In patients who largely lack epistemic trust, a 
mental process focus is indicated. Yet, as noted, patients with less comorbidity in terms of 
BPD pathology may also benefit from a mentalizing or metacognitive focus, as is also 
demonstrated by studies demonstrating the effectiveness of mindfulness-based approaches in 
patients with mood disorders, although it must be said that these approaches seem particularly 
effective in chronically depressed patients, many of whom probably have comorbid 
personality pathology [149, 150, 6]. In patients with greater epistemic trust, a mental process 
focus may be easier to combine with a mental representation focus and with the use of more 
“traditional” expressive techniques.  
Over the past years, together with a number of colleagues, we have developed 
Dynamic Interpersonal Therapy (DIT), a treatment model that combines both perspectives. 
DIT illustrates how a combination of a mental representation and mental process approach 
may be used in a brief treatment format aimed at treating depressed patients who may have 
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some, but not marked, BPD features. For the more severe spectrum of depressed patients with 
marked BPD features, Mentalization-Based Treatment for BPD might be more indicated. 
When working with patients with BPD features, the first task at hand is often to establish a 
trusting relationship that can be the basis for exploring the influence of mental states on 
mood, something that is taken for granted in many treatment models for depression.  
Dynamic Interpersonal Therapy (DIT) for depression 
DIT is an integrative treatment that represents a distillation of evidence-based brief 
psychoanalytic/psychodynamic treatment models [151, 5]. DIT incorporates a mental 
representation and a mentalizing approach. With regard to the first of these, this is done by 
taking a so-called Interpersonal Affective Focus (IPAF) as the focus of the treatment. More 
traditional supportive and expressive techniques are used to develop this focus in interaction 
with the patient and to work it through. DIT also includes a strong mentalizing focus, using 
more directive and mentalizing interventions to increase reflective capacities in the patient. 
Hence, rather than focusing on content, a focus on fostering reflective processes is often 
thought to be equally if not more effective in DIT. Similarly, transference interpretations are 
limited, and are mainly made in order to clarify the IPAF, particularly in patients who have a 
strong transference response (which, if unaddressed, hampers the therapeutic process). The 
use of the transference in DIT is also appropriate when patients have few interpersonal 
relationships and thus the therapeutic relationship becomes an important vehicle to identify 
and work through the IPAF. 
This is congruent with studies that show a negative relationship between a high 
frequency of transference interpretations and both the therapeutic relationship and outcome in 
brief and long-term psychoanalytic treatment, even in patients with high levels of personality 
functioning [152]. A study by Hoglend and colleagues [153, 154], for instance, found no 
differences in the efficacy of two psychodynamic treatments that differed only in terms of the 
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use of transference interpretation (i.e., with and without the use of such interpretations) both 
at treatment termination and at 3-year follow-up, except in patients with low levels of 
personality functioning. These patients responded better to treatment with a low frequency of 
transference interpretations (0–3 per session) compared to treatment without transference 
interpretations. Moreover, in these patients, increases in insight mediated the relationship 
between transference interpretations and improvements in relational functioning [155]. 
Hence, transference interpretations may be a “high-risk/high-gain” strategy in relation to 
patients with (marked) BPD features: they may lead to increased insight but also increased 
defensiveness and disturbances of the therapeutic relationship and the therapeutic process 
[156]. The other important implication from this study is that, in patients with higher levels of 
functioning, a more general interpersonal focus that does not use transference interpretations 
is as effective. These findings provide further confirmation, in our opinion, of the need to 
address the immediacy and strong nature of attachment imperatives (and subjective 
experiences more generally) – fuelled by epistemic hypervigilance and attachment 
disorganization – in patients with (marked) BPD features. In patients with more epistemic 
trust, as in patients with organized insecure attachment features, such a focus is less intensely 
required. 
Similarly, while past experiences and their influence on current functioning are 
acknowledged in DIT, they are not the major focus. The focus is on the IPAF in DIT, that is, 
the patient’s current interpersonal functioning as it relates to the presenting symptoms, 
keeping in mind that a discussion of past experiences, and particularly traumatic experience, 
may easily overwhelm patients’ mentalizing capacities. 
DIT is a time-limited (16 sessions) intervention that thus primarily targets the capacity 
for mentalizing (mental process focus) and connections between mood symptoms and 
interpersonal functioning (mental presentation focus).  
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DIT consists of three phases (initial, middle and ending), each with specific aims and 
strategies. The primary task of the initial phase (sessions 1–4) is to identify one dominant and 
recurring unconscious interpersonal pattern, the IPAF, which is assumed to be central to the 
onset and/or maintenance of the depressive symptoms. This pattern is underpinned by a 
particular representation of self-in-relation-to-an-other that characterizes the patient’s 
interpersonal style and leads to difficulties in his/her relationships. These representations are 
typically linked to particular affect(s) and defensive maneuvers. Affects are understood to be 
responses to the activation of a specific self-other representation in the patient’s mind. This 
particular way of formulating derives from Kernberg’s work [157], and is thus heavily 
influenced by mental representation models. For example, an IPAF might focus on a self-
representation as “helpless victim” in relation to others whom the individual feels constantly 
criticize and neglect him/her. The defensive function of this constellation is to defend against 
underlying feelings of frustration and aggression and to reverse the role and triumph over 
criticizing others. These patterns and their high (interpersonal) costs are highlighted, which 
leads the patient to relinquish these patterns. Hence the focus on the IPAF combines a mental 
representation and mentalizing approach. In patients with marked impairments in 
mentalizing, interventions often address much more basic dynamics, such as (a) affect 
recognition and affect differentiation, (b) linking affect to depressed mood and anxiety, and 
(c) linking affect to the IPAF. Hence, both components – the mental representation and the 
mental process focus – allow the therapist to tailor his/her interventions to the specific 
mentalizing capacities within the session, with greater weight to mentalizing and supportive 
interventions in patients with BPD features. 
The middle phase (sessions 5–12) involves: (a) maintaining a focus on the agreed 
IPAF, (b) helping the patient to identify areas of difficulty in his/her relationships and 
understand his/her characteristic ways of managing these difficulties, pointing out the 
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interpersonal “costs” of these strategies; (c) stimulating the patient’s capacity to think about 
and understand his/her thoughts and feelings (the mentalizing focus), and how these underpin 
strange or self-defeating behaviors and patterns of relating; (d) attending to the patient’s 
affective state; (e) focusing on the therapeutic relationship as a live example of the IPAF in 
action; (f) helping the patient practice the skill of recognizing internal states (feelings and 
thoughts, wishes, etc.), and connecting these to the week’s events and to the IPAF. This phase 
may prove very difficult for patients with BPD features, as they may be easily overwhelmed 
by more interpretive work; thus, in these patients, a greater emphasis on support, validation, 
and mentalizing is needed. Often, it is very difficult to delineate a specific IPAF as the focus 
of treatment, as the IPAF (and thus the use of attachment hyperactivating and deactivating 
strategies) seems to change constantly. For instance, at the start of the treatment the patient 
might present as a hopeless victim in the hands of others. This pattern might soon change to 
the opposite direction, only to then change back to the original pattern and so on, leading to 
confusion in both the patient and the therapist. This reflects, in our opinion, a disorganization 
of the attachment system that seriously impacts on the treatment process, as neither the 
patient nor the therapist is sure what exactly they are trying to address from a mental 
representation perspective – particularly as the patient typically lacks the capacity to 
simultaneously consider both patterns and their interrelationship. This should alert the 
clinician to the possibility that DIT may not be the treatment of choice for this patient. 
The final phase (sessions 13–16) is devoted to helping the patient explore the 
affective experience and the conscious and unconscious meaning of the therapy ending, 
reviewing the progress made, and helping the patient to anticipate future difficulties or 
vulnerabilities. Work in these final sessions involves: (a) systematically addressing the 
patient’s feelings, unconscious fantasies, and anxieties about the termination of therapy; (b) 
responding to any signs of regression (e.g., a deterioration in the patient’s symptoms) near the 
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end of treatment by linking this with the patient’s feelings and fantasies regarding endings; 
(c) helping the patient to review the therapy overall (e.g., whether he/she has achieved his/her 
initial aims); and (d) the therapist writing a “goodbye” letter for the patient, which sums up 
the original agreed formulation and what progress has been made in working on the issues 
identified in it.  
Responses to the impending end of treatment are more likely to be more extreme in 
patients with BPD features, and therapists may be “seduced” by the patient to offer additional 
sessions as the approaching end of treatment generates abandonment anxieties and feelings of 
aggression in the patient, leading the therapist to increasingly worry about the patient. Again, 
a more validating approach is helpful here, and lowering the patient’s level of arousal is 
needed before he/she can adopt a more reflective stance. 
Although DIT is currently a manualized, short-term treatment, the techniques and 
principles used can be flexibly integrated with other (longer-term) treatments. Patients with 
more marked BPD features, in particularly, may benefit from a longer, more open-ended 
treatment approach. This may focus in more detail on the relationship between current and 
past relationships and functioning, and aim at more profound changes in character.  
Earlier, we reviewed evidence suggesting that BPD features may impede treatment 
response in brief treatments. Whether this is also the case in DIT is ultimately an empirical 
question. Over the past decades, evidence for both more traditional intrapersonal and more 
interpersonal brief and long-term treatments in depression with and without comorbid 
personality pathology has been accumulating [158-162]. In line with these findings, a recent 
small pilot trial showed that DIT was associated with a significant reduction in symptoms in 
all but one case, to below clinical levels in 70% of the patients studied [63]. Further research 
is needed to investigate the influence of BPD features on DIT. A large randomized trial is 
currently underway that will address these issues. 
Psychodynamic Treatment for BPD and Mood Disorders 
 
28 
Mentalization-Based Treatment and mood problems in BPD patients 
MBT originated in the treatment of patients with BPD, many of whom struggle with 
intense and chronic feelings of depression [6]. The treatment evolved precisely out of 
dissatisfaction with more traditional, insight-oriented treatments, as these overestimate the 
mentalizing capacities of BPD patients. Here, we present the core principles and techniques 
of MBT, with a focus on depression in BPD. We also review preliminary evidence suggesting 
that MBT may be particularly effective in reducing depression in BPD.  
 The MBT approach is based on a view that a core problem for many patients, and 
typically those with BPD, is their vulnerability to a loss of mentalizing in combination with 
epistemic hypervigilance. MBT places mentalizing at the center of the therapeutic process. At 
its core is the argument that MBT works through the therapist establishing an enduring 
attachment relationship with the patient while continuously stimulating a mentalizing process 
in the patient.  
The basic aim of the treatment is to re-establish mentalizing when it is lost and 
maintain mentalizing when it is present. Therapists are expected to focus on the patient’s 
subjective sense of self. To do so, they need to (a) identify and work with the patient’s 
mentalizing capacities; (b) represent internal states both in themselves and in the patient; (c) 
focus on these internal states; and (d) sustain this focus in the face of constant challenges by 
the patient over a significant period of time. In order to achieve this level of focus, 
mentalizing techniques need to be (a) offered in the context of an attachment relationship; (b) 
consistently applied over time; and (c) used to reinforce the therapist’s capacity to retain 
mental closeness with the patient. Congruent with our assumption of severe attachment and 
mentalizing impairments in patients with BPD, which typically give rise to epistemic 
hypervigilance, MBT is manualized to facilitate the achievement of these primary goals, and 
entails a strong focus on mentalization techniques while avoiding harm to a group of patients 
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who may be particularly vulnerable to the negative effects of psychotherapeutic interventions. 
This may be particularly important when dealing with feelings of depression in patients with 
severe BPD features. As noted above, depressive experiences in these patients are often 
marked by excessive feelings of self-criticism, emptiness, and meaninglessness, and 
associated with a high risk of self-harm. In such states of mind, a focus on “insight”, 
particularly when focused on events in the past and when combined with a more neutral and 
distant therapeutic stance, is at best unhelpful and at worst likely to be iatrogenic. The MBT 
approach therefore entails a titrated but more or less exclusive focus on the BPD patient’s 
current mental state and with special attention paid to avoid generating iatrogenic effects, as 
this focus inevitably activates the attachment system. Hence, treatment should avoid 
situations where patients are expected to talk of mental states that they cannot link to 
subjectively felt reality; this is particularly important when speaking about depressive 
experiences,. When feeling depressed, BPD patients all too readily revert to psychic 
equivalence mode, rendering depressed feelings even more painful and real, or to an extreme 
pretend mode, leading to profound feelings of helplessness and self-criticism. Thus, the MBT 
approach involves (a) a de-emphasis of “deep” unconscious interpretations in favor of 
conscious or near-conscious content addressing the here and now (e.g., “what happened just 
now that you feel like this?”); (b) a modification of the therapeutic aim, especially with 
severely disturbed patients, from insight to recovery of mentalization (i.e., achieving 
representational coherence and integration) (e.g., “I can see that you feel rejected, but let us 
pause and reflect for a minute on what just happened, and what he could have meant by 
saying that to you”); (c) careful avoidance of the use of descriptions of complex mental states 
(e.g., conflict, ambivalence, unconscious) that are incomprehensible to a person whose 
mentalizing is vulnerable, and instead sticking to the here and now or “working memory”; (d) 
avoidance of extensive discussion of past trauma except in the context of reflecting on the 
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patient’s current perceptions of the mental states of maltreating figures and changes in their 
own mental state from being a victim in the past versus their experiences now. As noted, 
patients with BPD features often tend to dwell on traumatic experiences in the past, 
especially when depressed; this can lead to hypomentalizing–hypermentalizing cycles (“I am 
abused, I am bad, there is nothing that anyone can do about this, I am beyond help – what if 
this never happened, if he hadn’t done that to me, my life could have looked completely 
different; I often think about this, and it tends to drive me crazy, it is all so painful”). These 
cycles tend to spiral out of control and lead, in a teleological mode, to increasing thoughts 
about self-harm and/or suicidality. Hence, in MBT, instead of encouraging the patient to 
explore such thoughts further, he/she is redirected toward exploring the influence of these 
thoughts on current thoughts and feelings and/or their relation to current events. 
The theoretical model proposed in this chapter also implies that in order to maximize 
the impact on the (depressed) patient’s ability to think about thoughts and feelings in 
relationship contexts, especially in the early phases of treatment, the therapist is probably 
most helpful when his/her interventions (a) are simple and easy to understand, (b) are affect 
focused, (c) actively engage the patient, (d) focus on the patient’s mind rather than on his/her 
behavior, (e) relate to a current event or activity – whatever is the patient’s currently felt 
mental reality (in working memory), (f) make use of the therapist’s own mind as a model 
(e.g., by the therapist disclosing his/her anticipated reaction in response to the event being 
discussed, i.e., talking to the patient about how the therapist anticipates that he/she might 
react in the same situation), (g) are flexibly adjusted in complexity and emotional intensity in 
response to the intensity of the patient’s emotional arousal (i.e., withdrawing when arousal 
and attachment are strongly activated).  
The key task of therapy is thus to promote curiosity about the way mental states 
motivate and explain the actions of self and others, even in depressed states of mind (i.e., 
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“finding meaning and coherence where none is felt or expected”). Therapists achieve this 
through the judicious use of the “inquisitive stance”, in which they highlight their own 
interest in the mental states underpinning behavior, qualify their own understanding and 
inferences (and show respect for the opaqueness in mental states), and demonstrate how such 
information can help the patient to make sense of his/her experiences. This inquisitive yet 
“not-knowing” stance is often exactly the opposite of the depressed patient’s state of mind, 
which is characterized by a lack of curiosity to explore mental states, or excessive certainty 
about mental states of the self and others. Pseudomentalization and other fillers that are 
particularly characteristic of depressed states (e.g., “All previous treatments have failed, I am 
a patient who does not respond to any treatment, nobody knows what to do with me”), and 
which replace genuine mentalization, must be explicitly identified by the therapist, and the 
lack of practical success associated with them should be clearly explained (“Well, I can see 
how you feel, and I can begin to understand why you feel like that, but it is not really helping 
us today, as you yourself said that these feelings drag you down”). In this way, MBT 
therapists can help their patients to learn about how they think and feel about themselves and 
others, how their thoughts and feelings shape their responses to others, and how “errors” in 
understanding self and others may lead to inappropriate actions.  
Hence, working with depressed mood in MBT typically entails the following 
sequence, which closely follows the more general MBT approach: (a) the therapist identifies 
a break in mentalizing (described above as psychic equivalence, pretend mode, or teleological 
mode of thought) as a result of depressed mood (“I feel so helpless, everything I do is bound 
to fail, I cannot see where this is leading us”); (b) the patient and therapist “rewind” to the 
moment before the break in subjective continuity (“What happened just now so that you feel 
like that – is it related to something that I said?”); (c) the current emotional context for the 
break is explored by identifying the momentary affective state between patient and therapist 
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(“You started talking about your job, and this is what seems to have happened, you became 
very self-critical”); (d) the therapist explicitly identifies and acknowledges their own 
contribution to the break in mentalizing (“Is it related to something that I said or did?”); and 
(e) the therapist seeks to help the patient understand the mental states implicit in the current 
state of the patient–therapist relationship (to mentalize the transference) (“When you said 
that, I started to feel helpless as well”).  
The therapist’s mentalizing therapeutic stance throughout this process should include: 
(a) humility deriving from a sense of “not-knowing” (“Well, I can see that you feel helpless 
now, but I want to understand why that is, because I am concerned about you and why you 
feel like that”); (b) whenever possible, taking time to identify differences in perspectives 
(“Well, you seem very sure that he said that to hurt you, but there may perhaps be other 
reasons for him saying that”), (c) legitimizing and accepting such different perspectives (“I 
now can see why you thought that, but can you accept that he may have meant something 
different?”); (d) active questioning of the patient in relation to his/her experience, asking for 
detailed descriptions of experience (“what” questions) rather than explanations (“why” 
questions) (“So what did you feel then?”); and (e) eschewing the need to understand what 
makes no sense (i.e., saying explicitly that something is unclear) (“Sorry, but you lost me 
there”).  
An important component of the mentalizing stance is the therapist monitoring his/her 
own mistakes and owning up to them. This not only models honesty and courage through 
such acknowledgments, and tends to lower the patient’s arousal through the therapist taking 
responsibility, but it also offers valuable opportunities to explore how mistakes can arise out 
of inaccurate assumptions about mental states, which are opaque, and how such 
misunderstandings can lead to massively aversive experiences. Importantly, through “staying 
with the patient” even when the patient feels completely helpless and hopeless, a sense of 
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concern and controllability is communicated – that is, that these states of mind are not as 
threatening, uncontrollable and meaningless as they seem.  
In this context, it is important to be aware that the therapist is constantly at risk of 
losing his/her capacity to mentalize in the face of a nonmentalizing patient. Especially when 
the patient is severely depressed, the therapist can feel as if they are being “sucked into a 
black hole”, leading to hypomentalizing; alternatively, the therapist may be in such a state of 
high arousal, for example because of the patient’s threats to self-harm, that she/he feels 
compelled to intervene teleologically (e.g., by prescribing medication or having the patient 
hospitalized). Consequently, we consider therapists’ occasional enactments as an acceptable 
concomitant of the therapeutic alliance, and something that simply has to be owned up to. As 
with other instances of breaks in mentalizing, such incidents require that the process is 
“rewound” and the incident explored. Hence, in this collaborative patient–therapist 
relationship, both partners involved have a joint responsibility to understand such enactments. 
Research evidence for the effectiveness of MBT for the treatment of BPD, including 
depression in BPD, is consolidating. A follow-up study of BPD patients 5 years after all 
treatment was complete (and 8 years after initial entry into treatment) compared patients who 
had been treated with MBT versus those who received treatment as usual (TAU), and found 
that those who received MBT remained better than the TAU group. Superior levels of 
improvement were shown for diagnostic status (13% vs. 87%), service use (2 years vs. 3.5 
years), and other measurements such as use of medication, global function, and vocational 
status. Importantly, MBT was also superior in reducing levels of suicidality (23% in the MBT 
group vs. 74% in TAU group) [163] and in reducing the severity of depression as assessed 
with the Beck Depression Inventory (unpublished data).  
In relation to adolescence and the emergence of BPD traits, a more recent study by 
Rossouw and Fonagy [164] comparing the effectiveness of a version of MBT developed 
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specifically for adolescents (MBT-A) for adolescents who self-harm against TAU found that 
MBT-A was more effective in reducing both self-harm behavior and depression. The 
improvements generated by MBT-A appear to have been mediated by improved levels of 
mentalization, reduced attachment avoidance, and amelioration of their emergent BPD 
features: individuals in the MBT-A group showed a recovery rate of 44%, compared to 17% 
in the TAU group.  
 
Conclusions 
This chapter has presented a mentalizing approach to mood problems and BPD. We consider 
patients with BPD and mood problems to be situated on a continuum. However, four related 
features seem to distinguish, in relative terms, individuals with mood problems with and 
without marked BPD features: (a) the nature of their depressive experiences; (b) the severity 
of their mentalizing impairments, and particularly the extent they feel pressured to externalize 
alien-self parts; (c) insecure, but organized, attachment in response to stress and arousal 
versus disorganized attachment; and (d) problems with epistemic trust versus epistemic 
hypervigilance. We described DIT, a manualized treatment for depressed patients without 
marked BPD features that combines a mental representation and mental process focus that 
can be flexibly tailored to individual patients. For patients with more marked BPD features, 
more traditional and longer-term MBT might be indicated, as a result of the more marked 
impairments in mentalizing, attachment, and high levels of epistemic hypervigilance in these 
patients. 
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